{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:18:12Z","timestamp":1790147892297,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005301","name":"American College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clbc.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:58:53Z","timestamp":1748084333000},"page":"589-599.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast Cancer"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-9394","authenticated-orcid":false,"given":"Mar\u00eda","family":"Herr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Bilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hijazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mohanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-1646","authenticated-orcid":false,"given":"Zeina","family":"Nahleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","article-title":"Breast cancer heterogeneity and its implication in personalized precision therapy","volume":"12","author":"Guo","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.clbc.2025.05.018_bib0003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcdb.2016.08.025","article-title":"Molecular heterogeneity in breast cancer: state of the science and implications for patient care","volume":"64","author":"Ellsworth","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.clbc.2025.05.018_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4809183","article-title":"Precision medicine for breast cancer: the paths to truly individualized diagnosis and treatment","volume":"2018","author":"Harris","year":"2018","journal-title":"Int J Breast Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.018_bib0005","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies\u2013improving the management of early breast cancer: st Gallen International Expert Consensus on the primary therapy of early Breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.018_bib0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.clbc.2025.05.018_bib0007","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.018_bib0008","first-page":"93","article-title":"The Eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0009","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","article-title":"NCCN Guidelines\u00ae insights: breast Cancer, version 4.2023","volume":"21","author":"Gradishar","year":"2023","journal-title":"J Nat Compr Can Netw"},{"issue":"22","key":"10.1016\/j.clbc.2025.05.018_bib0010","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1200\/JCO.19.00945","article-title":"Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx","volume":"37","author":"Andre","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0011","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1373\/clinchem.2006.076497","article-title":"Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer","volume":"53","author":"Cronin","year":"2007","journal-title":"Clin Chem"},{"issue":"17","key":"10.1016\/j.clbc.2025.05.018_bib0012","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1002\/cncr.32956","article-title":"Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base","volume":"126","author":"Ibraheem","year":"2020","journal-title":"Cancer"},{"issue":"6871","key":"10.1016\/j.clbc.2025.05.018_bib0013","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van \u2019t Veer","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.018_bib0014","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10147-018-1373-5","article-title":"Clinical target sequencing for precision medicine of breast cancer","volume":"24","author":"Tsuchida","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.05.018_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221081077","article-title":"Oncotype DX recurrence score in premenopausal women","volume":"14","author":"Zhang","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0016","doi-asserted-by":"crossref","first-page":"346","DOI":"10.6004\/jnccn.2017.0034","article-title":"Racial and ethnic disparities in oncotype DX test receipt in a statewide population-based study","volume":"15","author":"Davis","year":"2017","journal-title":"J Nat Compr Can Netw"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-017-4587-8","article-title":"Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results","volume":"168","author":"Press","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0018","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41598-023-27578-4","article-title":"Racial disparities in breast cancer treatment patterns and treatment related adverse events","volume":"13","author":"Stabellini","year":"2023","journal-title":"Sci Rep"},{"issue":"S19","key":"10.1016\/j.clbc.2025.05.018_bib0019","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/cncr.34632","article-title":"Racial disparities in the screening mammography continuum within a heterogeneous health care system","volume":"129","author":"Ganguly","year":"2023","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2025.05.018_bib0020","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","article-title":"Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research","volume":"18","author":"Wheeler","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2025.05.018_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.674736","article-title":"A critical theoretical approach to cancer disparities: breast cancer and the social determinants of health","volume":"9","author":"Gehlert","year":"2021","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0025","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"434","key":"10.1016\/j.clbc.2025.05.018_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18+ years","volume":"91","author":"Rubin","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.clbc.2025.05.018_bib0027","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2024. Available from: https:\/\/www.R-project.org\/. Accessed June 16, 2015."},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11606-020-06064-x","article-title":"Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center","volume":"36","author":"Chapman-Davis","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0029","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41436-018-0349-1","article-title":"Disparities in genetic services utilization in a random sample of young breast cancer survivors","volume":"21","author":"Nikolaidis","year":"2019","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/cge.14100","article-title":"Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system","volume":"101","author":"Powell","year":"2022","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.018_bib0031","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-21-0929","article-title":"Oncotype DX risk recurrence score and total mortality for early-stage breast cancer by race\/ethnicity","volume":"31","author":"Moore","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.018_bib0032","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1200\/JCO.2015.63.2489","article-title":"Racial variation in the uptake of oncotype DX testing for early-stage breast cancer","volume":"34","author":"Roberts","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0033","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaoncol.2020.7320","article-title":"Association of Race\/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women","volume":"7","author":"Hoskins","year":"2021","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.018_bib0034","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/tbj.13971","article-title":"Update on multi-gene panel testing and communication of genetic test results","volume":"26","author":"Reid","year":"2020","journal-title":"Breast J"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.018_bib0035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamasurg.2020.1495","article-title":"Association of Medicaid expansion under the affordable care act with breast cancer stage at diagnosis","volume":"155","author":"Le Blanc","year":"2020","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0036","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1200\/JCO.2016.69.9835","article-title":"Access to accredited cancer hospitals within federal exchange plans under the Affordable Care Act","volume":"35","author":"Kehl","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.018_bib0037","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaoncol.2015.6125","article-title":"Effects of narrow networks on access to high-quality cancer care","volume":"2","author":"Schleicher","year":"2016","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.05.018_bib0038","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1200\/JCO.19.01484","article-title":"Insurance networks and access to affordable cancer care","volume":"38","author":"Kehl","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2025.05.018_bib0039","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/gim.2015.218","article-title":"Implementation of the 21-gene recurrence score test in the United States in 2011","volume":"18","author":"Lynch","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.clbc.2025.05.018_bib0040","series-title":"Health Literacy: A Prescription to End Confusion","author":"Nielsen-Bohlman","year":"2004"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.018_bib0041","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41436-018-0402-0","article-title":"Cancer communication research in the era of genomics and precision medicine: a scoping review","volume":"21","author":"Kaphingst","year":"2019","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.clbc.2025.05.018_bib0042","first-page":"78","article-title":"How do women decide? Accepting or declining BRCA1\/2 testing in a nationwide clinical sample in the United States","volume":"9","author":"Sankar","year":"2006","journal-title":"Community Genet"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0043","first-page":"S44","article-title":"Psychosocial effects of multigene panel testing in the context of cancer genomics","volume":"49","author":"Hamilton","year":"2019","journal-title":"Hastings Cent Rep"},{"issue":"5","key":"10.1016\/j.clbc.2025.05.018_bib0044","article-title":"Socioeconomic status and interest in genetic testing in a US-based sample","volume":"10","author":"Dusic","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.clbc.2025.05.018_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canep.2018.02.003","article-title":"Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities","volume":"53","author":"Sighoko","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.clbc.2025.05.018_bib0046","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jnci\/djac217","article-title":"Changes in geographic accessibility to mammography by state and rural-urban status, United States, 2006-2022","volume":"115","author":"Wiese","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2025.05.018_bib0047","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1475-6773.12081","article-title":"Geographic disparities in mammography capacity in the South: a longitudinal assessment of supply and demand","volume":"49","author":"Eberth","year":"2014","journal-title":"Health Serv Res"},{"issue":"7","key":"10.1016\/j.clbc.2025.05.018_bib0048","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19110","article-title":"Opportunities for improving system-level barriers to biomarker testing for metastatic colorectal cancer","volume":"7","author":"Adekunle","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0049","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/jnci\/djz192","article-title":"Adjuvant chemotherapy for older patients with breast cancer: when is the pain worth the gain?","volume":"112","author":"Freedman","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.clbc.2025.05.018_bib0050","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1200\/JOP.2014.001388","article-title":"Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)","volume":"10","author":"Klepin","year":"2014","journal-title":"J Oncol Pract"},{"issue":"27","key":"10.1016\/j.clbc.2025.05.018_bib0051","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clbc.2025.05.018_bib0052","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ejhg.2012.271","article-title":"Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010","volume":"21","author":"Henneman","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.clbc.2025.05.018_bib0053","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jnci\/djz189","article-title":"Simulation of chemotherapy effects in older breast cancer patients with high recurrence scores","volume":"112","author":"Chandler","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.clbc.2025.05.018_bib0054","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50237","article-title":"Comparison of capture rates of the National Cancer Database across race and ethnicity","volume":"6","author":"Satpathy","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925001491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925001491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:56:23Z","timestamp":1762548983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925001491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1526820925001491"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.05.018","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}